Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

计划入组 10 人 · 首次发布于 2004 年 4 月 28 日

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

计划入组 31 人 · 首次发布于 2025 年 6 月 10 日

A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

计划入组 1 人 · 首次发布于 2025 年 5 月 21 日

CNS gene therapy program (undisclosed) (Exegenesis Bio)

undisclosed gene therapy (Intrathecal, CNS diseases)

undisclosed gene therapy (AAV5, CNS diseases)

CELL AND GENE THERAPY CATAPULT

United Kingdom

CNS Pharmaceuticals

United States

CNS NETWORK INC

United States

AbbVie Advances CNS Gene Therapy with Capsida Through $40 Million Option

Coave Therapeutics Unveils coAAV-CSF-01: A Breakthrough Gene Therapy Vector for CNS Diseases

Apertura Gene Therapy Launches Open Aperture Program to Democratize Access to CNS-Targeting AAV Capsid